2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

 

ASCO® 2024 Summary: "PD-1-Refractory Advanced Melanoma - Getting to the Finish Line"

145 views
June 10, 2024

Chapters

Overview & PD-1-Refractory Melanoma Challenges

00:00

FDA Approvals & Treatment Results

01:12

Clinical Trial Results & Biomarker Insights

02:40

Future Directions & Novel Therapies

08:31

Comments 0
Login to view comments. Click here to Login